Rational Design of Putative Dual-Target Opioid-Dopaminergic Casomorphin–Ranatensin Hybrid Peptides: Computational Modeling and Preliminary Antiproliferative Evaluation
Despite advances in oncology, cancer remains a leading cause of mortality worldwide, and both μ-opioid receptor (MOR) and dopamine D2 receptor (D2R) signaling have been implicated in the regulation of tumor proliferation, survival, and progression, positioning them as attractive targets for multifunctional anticancer s...